DLRHX Mutual Fund

NAV$27.87

AUM$2M

TER1.46%

Holdings106

See how much of DLRHX you already own

Just $25 once·$69/mo·Download sample

X-ray my portfolio free

DLRHX Mutual Fund

NAV$27.87

Nomura Healthcare Fund Class R

AUM$2M

TER1.46%

Holdings106

See how much of DLRHX you already own

Just $25 once·$69/mo·Download sample

X-ray my portfolio free

Overview Performance Chart Dividends Top Holdings All Holdings Sectors Geography Similar Compare Overlap

Showing top 50 of 106 holdings · as of Mar 31, 2026

DLRHX holdings, by weight
#	Ticker	Name	Weight	Cumulative	Shares	Mkt value	Share chg	Sector	Industry
1	—	Ucb SaHealth Care · Pharmaceuticals	5.90%	5.9%	130,137	$39.21M	-	Health Care	Pharmaceuticals
2	REGN	Regeneron Pharmaceuticals, Inc.Health Care · Pharmaceuticals	5.46%	11.4%	47,000	$36.31M	-	Health Care	Pharmaceuticals
Share changes, sector and industry · Pro
3	PFE	Pfizer Inc	4.84%	16.2%	1,145,000	$32.15M
4	GILD	Gilead Sciences	4.40%	20.6%	210,000	$29.27M
5	ABBV	AbbVie Inc.	4.09%	24.7%	125,000	$27.19M
6	MRK	Merck & Company Inc	3.89%	28.6%	215,000	$25.86M
7	—	AstraZeneca PLC	3.86%	32.4%	131,243	$25.66M
8	—	Chugai Pharmaceutical Co. Ltd. Com Stk	3.73%	36.2%	450,000	$24.82M
9	LLY	Eli Lilly & Co.	3.60%	39.8%	26,000	$23.91M
10	RHHVF	Roche Holding Ag-Genussch	3.30%	43.1%	55,000	$21.95M
11	UNH	Unitedhealth Group Inc	2.85%	45.9%	70,000	$18.94M
12	ELV	Elevance Health Inc	2.77%	48.7%	63,000	$18.44M
13	AMGN	Amgen Inc.	2.49%	51.2%	47,000	$16.54M
14	VTRS	Viatris Inc.	2.38%	53.6%	1,170,018	$15.81M
15	BSX	Boston Scientific Corp.	2.36%	55.9%	250,000	$15.69M
16	HALO	Halozyme Therapeutics Inc	2.14%	58.1%	220,000	$14.22M
17	SNY	Sanofi SA	1.74%	59.8%	120,000	$11.59M
18	—	Nvaesrtex Pharmaceuticals Inc	1.68%	61.5%	25,000	$11.16M
19	ILMN	Illumina, Inc.	1.67%	63.2%	90,000	$11.09M
20	VKTX	Viking Therapeutics Inc	1.62%	64.8%	330,100	$10.74M
21	—	Alkermes Plc. Ordinary Shares	1.54%	66.3%	290,000	$10.25M
22	ALNY	Alnylam Pharmaceuticals Inc.	1.49%	67.8%	30,000	$9.93M
23	FNMA	Federal National Mortgage Association	1.42%	69.2%	1,300,000	$9.44M
24	—	Roivant Sciences Ltd. Common Shares	1.41%	70.6%	338,181	$9.37M
25	NBIX	Neurocrine Biosciences Inc	1.39%	72.0%	70,000	$9.22M
26	COGT	Cogent Biosciences Inc	1.33%	73.4%	230,000	$8.85M
27	RCUS	Arcus Biosciences Inc	1.23%	74.6%	379,100	$8.19M
28	INCY	Incyte Corp.	1.13%	75.7%	80,000	$7.53M
29	ZBH	Zimmer Biomet Holdings	1.09%	76.8%	80,000	$7.23M
30	TARS	Tarsus Pharmaceuticals Inc	1.05%	77.9%	100,000	$7.01M
31	FMCC	Freddie Mac Preferred Stock	1.01%	78.9%	1,050,000	$6.72M
32	DGX	Quest Diagnostics Inc	0.88%	79.7%	30,000	$5.88M
33	BMRN	Biomarin Pharmaceutical Inc.	0.85%	80.6%	100,000	$5.65M
34	TFDXX	BlackRock Liquidity Funds FedFund Institutional Shares	0.81%	81.4%	5,357,802	$5.36M
35	CVS	Cvs Health Corp.	0.81%	82.2%	75,000	$5.39M
36	FIGXX	Fidelity Inv Mmkt Govt-I 12/31/2031	0.81%	83.0%	5,357,802	$5.36M
37	FGTXX	Goldman Sachs Fin Gov 465 Institut	0.81%	83.8%	5,357,802	$5.36M
38	MVRXX	Morgan Stanley Institutional Liquidity Funds - Government Portfolio - Institutional Class	0.81%	84.6%	5,357,802	$5.36M
39	ANAB	Anaptysbio Inc	0.78%	85.4%	93,732	$5.20M
40	BIIB	Biogen Inc.	0.77%	86.2%	28,000	$5.13M
41	—	Abivax Sa Sponsored Adr (1 Ads : 1 Ordinary)	0.75%	86.9%	45,000	$5.01M
42	JNJ	Johnson & Johnson -	0.74%	87.7%	20,000	$4.89M
43	—	Stryker Corp 3.375 11/25	0.74%	88.4%	15,000	$4.93M
44	VIR	Vir Biotechnology Inc	0.67%	89.1%	500,000	$4.48M
45	GRAL	Grail Inc Common Stock Usd	0.66%	89.8%	85,000	$4.39M
46	RIGL	Rigel Pharmaceuticals Inc	0.65%	90.4%	160,000	$4.33M
47	SNDX	Syndax Pharmaceuticals Inc	0.63%	91.0%	180,000	$4.20M
48	—	Uniqure N.V. Ordinary Shares	0.63%	91.7%	258,211	$4.22M
49	MDGL	Madrigal Pharmaceuticals Inc	0.55%	92.2%	7,000	$3.66M
50	TBPH	Theravance Biopharma Inc	0.51%	92.7%	208,783	$3.39M
More holdings · Pro

FundXLS Pro

See the other 56 holdings of DLRHX

X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.

Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

DLRHX Mutual Fund All Holdings

DLRHX holdings total 106 positions. The top 10 holdings account for 43.1% of the fund, led by Ucb Sa at 5.9%, Regeneron Pharmaceuticals, Inc. at 5.5%, Pfizer Inc at 4.8%.

DLRHX portfolio concentration is moderate, with the top 10 representing 43.1% of total assets. The largest sector exposure is Health Care at 72.4%.

DLRHX sectors provide a detailed breakdown. DLRHX overlap shows how holdings compare to other funds in your portfolio.